Regulatory Pathways & Market Authorization
Supporting healthcare organizations navigating regulatory pathways, market authorization strategies and market access initiatives across the United States, Mexico and selected international markets.
Understanding the regulatory landscape before market entry can help organizations evaluate risks, timelines and strategic opportunities
Regulatory Authorities & Frameworks
FDA
United States
U.S. Food and Drug Administration regulates a wide range of healthcare products to protect public health
COFEPRIS
Mexico
Comisión Federal para la Protección contra Riesgos Sanitarios regulates health products in Mexico
Health Canada
Canada
Health Canada oversees the safety, efficacy and quality of health products in the Canadian market.
Selected International Markets
Case-bycase basis
Regulatory frameworks
Supporting Market Access Through Regulatory Planning
Market Authorization Considerations
Regulatory Pathways frequently involve multiple considerations including:
- Product Classification
- Documentation requirements
- Labelling considerations
- Claims evaluation
- Registration strategies
- Importation considerations
- Commercialization planning
- Cross-border implications
Planning Before Submission
Related Healthcare Solutions
